Prostate Cancer: A Practical Approach to Current Management of Recurrent Disease
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference53 articles.
1. Cancer statistics, 2006;Jemal;CA Cancer J Clin,2006
2. The changing face of prostate cancer;Cooperberg;J Clin Oncol,2005
3. Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing;Paquette;Urology,2002
4. Prostate specific antigen only progression of prostate cancer;Moul;J Urol,2000
5. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?;Amling;J Urol,2001
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiandrogen abiraterone and docetaxel treatments affect Notch1, Jagged1 and Hes1 expressions in metastatic prostate cancer cells;Experimental and Molecular Pathology;2021-04
2. HIF1α promotes prostate cancer progression by increasing ATG5 expression;Animal Cells and Systems;2019-08-28
3. Phosphorylation of LIFR promotes prostate cancer progression by activating the AKT pathway;Cancer Letters;2019-06
4. Side Effects and Management of ADT for Prostate Cancer;Management of Advanced Prostate Cancer;2018
5. Treatment with abiraterone in metastatic castration-resistant prostate cancer patients progressing after docetaxel;Anti-Cancer Drugs;2017-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3